ScholarlyCommons at Penn
metadata only
Investigating Adipose Tissue Fibro-Adipogenic Progenitor Cell and Extracellular Matrix Crosstalk in the Context of Obesity and Weight Loss
Obesity and its consequential metabolic diseases continue to rise globally. The development of GLP1-based weight loss drugs has enabled millions of people to lose weight. However, these drugs represent an impermanent solution, with patients experiencing a dramatic rebound in their weight and metabol
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Investigating Adipose Tissue Fibro-Adipogenic Progenitor Cell and Extracellular Matrix Crosstalk in the Context of Obesity and Weight Loss#1041431
- The metabolic syndrome-cancer axis: global research trends and clinical landscapes.#354722
- Adipocytes in cancer a metabolic paradox and the dawn of novel therapeutics.#423016
- Nuclear Myosin 1 links genomic architecture to adipose tissue remodeling, metabolic inflammation and obesity in mice#347666
- Progranulin and CTRP3 in Metabolic Syndrome#870541
Record · ID 1041432
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive